Shopping Cart

Exicure Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

SKU
GDPH375392D
READ MORE
USD 250
Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750

Exicure Inc (Exicure), formerly AuraSense Therapeutics LLC, is a biotechnology company that develops and commercializes immunomodulatory and gene silencing drugs based on 3-dimensional spherical nucleic acid (SNA) constructs. Its technology portfo

READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Exicure Inc (Exicure), formerly AuraSense Therapeutics LLC, is a biotechnology company that develops and commercializes immunomodulatory and gene silencing drugs based on 3-dimensional spherical nucleic acid (SNA) constructs. Its technology portfolio includes SNA gene regulation platform and genetic analysis tools. The company's pipeline spans SNA based therapeutics for the treatment of psoriasis, bladder cancer, fibrosis, diabetic ulcers and inflammation. Exicure SNAs are also used as immunotherapeutic agents for the treatment of cancer and other infectious diseases. It works in collaboration with various pharmaceutical and biotechnology companies for exploring its SNA platform application against multiple diseases. Exicure is headquartered in Skokie, Illinois, the US.

Exicure Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Exicure Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Exicure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Exicure Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Exicure Secures Venture Funding 10

Exicure Raises USD14.8 Million Financing 10

AuraSense Therapeutics Raises USD4.4 Million in Extended Series C Financing 11

AuraSense Therapeutics Raises USD13.6 Million in Series C Financing 11

AuraSense Therapeutics Raises Funds Through Extended Series B Financing 12

AuraSense Therapeutics Secures Investment In Series B Financing 13

Licensing Agreements 14

Purdue Pharma Enters into Licensing Agreement with Exicure 14

Exicure Inc-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Appendix 19

Methodology 19

About GlobalData 19

Contact Us 19

Disclaimer 19


List Of Figure

List of Figures

Exicure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Exicure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

Exicure Inc, Pharmaceuticals & Healthcare, Key Facts 1

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Exicure Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Exicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Exicure Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Exicure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Exicure Secures Venture Funding 10

Exicure Raises USD14.8 Million Financing 10

AuraSense Therapeutics Raises USD4.4 Million in Extended Series C Financing 11

AuraSense Therapeutics Raises USD13.6 Million in Series C Financing 11

AuraSense Therapeutics Raises Funds Through Extended Series B Financing 12

AuraSense Therapeutics Secures Investment In Series B Financing 13

Purdue Pharma Enters into Licensing Agreement with Exicure 14

Exicure Inc, Key Competitors 16

Exicure Inc, Key Employees 17

To know more information on Purchase by Section, please send a mail to

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.